Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Contract

23 Mar 2021 07:00

RNS Number : 1013T
Biome Technologies PLC
23 March 2021
 

This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

23 March 2021

 

Biome Technologies plc

("Biome", the "Group" or the "Company")

Contract secured to accelerate US sales of coffee-pod filtration material

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, is pleased to announce that it has secured the anticipated contractual commitment with a second US end-customer to accelerate the commercialisation of its proprietary compostable filtration material. This important customer's business will support a significant portion of the Group's expected revenue growth in 2021 and beyond.

In the Company's circular to shareholders at the time of its fundraising last September, Biome identified this project as the most important growth driver for 2021 in support of its ambitious KPIs. In the subsequent trading update on 29 October 2020, it was further stated that the implementation was moving forward assuredly and initial orders were expected later in Q4 2020. These initial orders enabled the customer to test Biome's material extensively in the production environment, such production being enabled by supplementary equipment provided by the Group's Stanelco RF Technologies division ("RF Technologies"). This testing has proven successful and commercial production for consumer use began in Q1 2021.

This end-customer has now ordered further equipment, with a value US$70k and to be made by RF Technologies, that will help to unlock the use of Biome's compostable filtration material on a significant portion of the customer's installed capacity. It is anticipated that this will lead to significant additional revenues for the Group Bioplastics division during 2021.

This important customer commitment, and the commercial progress described, supports the Board's expectations of the continued rapid growth of the Bioplastics division and the current market expectations for the Group.

The Group is due to announce results for the year ended 31 December 2020 on Thursday, 25 March 2021.

-Ends-

 

For further information please contact: Biome Technologies plc

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

info@biometechnologiesplc.co.uk

Tel: +44 (0) 2380 867 100

www.biometechnologiesplc.com

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

Tel: +44 (0) 20 3328 5656

www.allenbycapital.com

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited.

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

 

www.biometechnologiesplc.com

www.biomebioplastics.com and www.thinkbioplastic.com 

www.stanelcorftechnologies.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTBIGDXLXDDGBD
Date   Source Headline
14th Jun 201012:31 pmRNSResult of Meeting
14th Jun 20107:00 amRNSResult of the Firm Placing, Placing and Open Offer
27th May 20104:15 pmRNSPublication of Prospectus
27th May 20107:00 amRNSFirm Placing and Placing and Open Offer
25th May 20104:40 pmRNSSecond Price Monitoring Extn
25th May 20104:35 pmRNSPrice Monitoring Extension
21st May 20104:40 pmRNSSecond Price Monitoring Extn
21st May 20104:35 pmRNSPrice Monitoring Extension
30th Apr 20104:40 pmRNSSecond Price Monitoring Extn
30th Apr 20104:35 pmRNSPrice Monitoring Extension
30th Apr 201010:36 amRNSAnnual Report and Accounts
29th Apr 20107:01 amRNSInterim Management Statement
29th Apr 20107:00 amRNSPreliminary Results
19th Apr 20107:00 amRNSUpdate re Novamont S.p.A infringement claims
16th Apr 20107:00 amRNSAnnual Information Update
17th Feb 20108:00 amRNSBiome Bioplastics new HT bioplastic
25th Jan 201010:30 amRNSStanelco re-brands bioplastics business
9th Dec 20098:00 amRNSOrders for Fibre Optics systems in Asia
3rd Dec 20097:00 amRNSStatement re share price movement
25th Nov 20094:40 pmRNSSecond Price Monitoring Extn
25th Nov 20094:35 pmRNSPrice Monitoring Extension
9th Nov 200910:06 amRNSHolding(s) in Company
6th Nov 20097:00 amRNSInterim Management Statement
21st Oct 20093:17 pmRNSHolding(s) in Company
20th Oct 20094:35 pmRNSPrice Monitoring Extension
8th Sep 20094:45 pmRNSHolding(s) in Company
4th Sep 20094:35 pmRNSPrice Monitoring Extension
3rd Sep 20094:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20094:35 pmRNSPrice Monitoring Extension
28th Aug 20097:00 amRNSInterim Results
13th Aug 20094:40 pmRNSSecond Price Monitoring Extn
13th Aug 20094:35 pmRNSPrice Monitoring Extension
7th May 20097:00 amRNSDirectors' Dealing
24th Apr 20091:42 pmRNSResult of Annual General Meeting
24th Apr 20097:00 amRNSInterim Management Statement
7th Apr 20097:00 amRNSAnnual Information Update
2nd Apr 20092:01 pmRNSDirector/PDMR Shareholding
1st Apr 20097:00 amRNSChange of Adviser
30th Mar 20095:36 pmRNSAnnual Report and Accounts and Notice of AGM
26th Mar 20094:35 pmRNSPrice Monitoring Extension
26th Mar 20097:00 amRNSPreliminary Results
19th Dec 20087:01 amRNSDirectorate Change
19th Dec 20087:00 amRNSDirectorate Change
7th Nov 20087:00 amRNSInterim Management Statement
10th Oct 200811:14 amRNSDirector/PDMR Shareholding
2nd Sep 200812:02 pmRNSHolding(s) in Company
29th Aug 20087:00 amRNSInterim Results
22nd Aug 20081:36 pmRNSHolding(s) in Company
30th Jul 20089:02 amRNSHolding(s) in Company
11th Jul 20087:00 amRNSNotifiable Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.